11A
MRK icon

10-15 Associates’s Merck MRK Stock Holding History

10-15 Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$14.8M Buy
186,584
+18
+0% +$1.41K 2.86% 8
2020
Q2 		$13.8M Buy
186,566
+1,594
+0.9% +$120K 2.78% 11
2020
Q1 		$13.6M Buy
184,972
+14,367
+8% +$1.13M 3.16% 5
2019
Q4 		$14.8M Buy
170,605
+1,744
+1% +$143K 2.79% 8
2019
Q3 		$13.6M Buy
168,861
+735
+0.4% +$58.9K 2.79% 7
2019
Q2 		$13.5M Buy
168,126
+5,596
+3% +$428K 2.92% 10
2019
Q1 		$12.9M Buy
162,530
+6,376
+4% +$477K 2.77% 11
2018
Q4 		$11.4M Buy
156,154
+1,196
+0.8% +$84.4K 2.79% 13
2018
Q3 		$10.5M Buy
154,958
+2,782
+2% +$177K 2.35% 20
2018
Q2 		$8.81M Buy
152,176
+4,886
+3% +$276K 1.98% 24
2018
Q1 		$7.66M Buy
147,290
+6,365
+5% +$344K 1.82% 25
2017
Q4 		$7.57M Buy
140,925
+2,710
+2% +$150K 1.81% 25
2017
Q3 		$8.44M Buy
138,215
+20,200
+17% +$1.22M 2.13% 24
2017
Q2 		$7.22M Buy
118,015
+945
+0.8% +$57.5K 2.03% 25
2017
Q1 		$7.1M Buy
117,070
+2,408
+2% +$146K 1.94% 22
2016
Q4 		$6.44M Sell
114,662
-26,187
-19% -$1.53M 1.81% 21
2016
Q3 		$8.39M Sell
140,849
-1,019
-0.7% -$59.6K 2.33% 16
2016
Q2 		$7.8M Buy
141,868
+6,642
+5% +$353K 2.24% 14
2016
Q1 		$6.83M Sell
135,226
-199
-0.1% -$9.75K 2.12% 20
2015
Q4 		$6.83M Buy
135,425
+9,209
+7% +$464K 1.98% 17
2015
Q3 		$5.95M Buy
126,216
+98,314
+352% +$5.22M 2.04% 20
2015
Q2 		$1.51M Buy
27,902
+215
+0.8% +$12.1K 0.47% 51
2015
Q1 		$1.52M Buy
27,687
+3
+0% +$170 0.51% 46
2014
Q4 		$1.5M Sell
27,684
-445
-2% -$24.8K 0.48% 48
2014
Q3 		$1.59M Buy
28,129
+375
+1% +$21.1K 0.54% 46
2014
Q2 		$1.53M Sell
27,754
-259
-0.9% -$14.1K 0.49% 48
2014
Q1 		$1.52M Sell
28,013
-102
-0.4% -$5.28K 0.49% 45
2013
Q4 		$1.34M Buy
+28,115
New +$1.29M 0.46% 47

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

10-15 Associates's MRK Position: Q3 2020 in Review

10-15 Associates increased its Merck (MRK) stake by 0.01% in Q3 2020, buying an estimated $1.41K and bringing the position to 186,584 shares worth $14.8M. The position accounts for 2.86% of the portfolio, ranked #8.

10-15 Associates first reported a position in MRK in Q4 2013 and has held it in 28 quarters since. The position peaked at $14.8M in Q4 2019. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • 10-15 Associates held 186,584 shares of Merck worth $14.8M as of Q3 2020.
  • 10-15 Associates bought 18 Merck shares in Q3 2020, an estimated $1.41K.
  • Merck made up 2.86% of 10-15 Associates's portfolio in Q3 2020, its #8 holding.
  • 10-15 Associates first reported a position in Merck in Q4 2013 and has held it in 28 quarters since.
  • 10-15 Associates's Merck position peaked at $14.8M in Q4 2019.
  • 2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.